Axis Securities recommends buying Abbott India Ltd. with a target price of Rs 31,420. The pharmaceutical company reported a 24% rise in fourth-quarter profit, driven by strong sales despite pricing caps on certain medicines. Promoters hold a 74.99% stake, and a dividend of Rs 410 per share is declared for fiscal year 2024.
| Subscribe To Our Free Newsletter |
